Reminder: ADVENTRX Presents Today at the Lippert/Heilshorn Life Sciences & MedTech Virtual Conference

SAN DIEGO, July 20 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) will present to investors as part of the Lippert/Heilshorn & Associates Life Sciences & Medical Technologies On-line Forum today at 10:00 a.m. Eastern time.

Interested parties can access a live audio webcast with slide presentation at www.adventrx.com, or from the PrecisionIR site at http://www.informedinvestors.com/IIF/IIF_Forum.asp?ForumID=160292. An archived presentation will be available for 30 days.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company whose product candidates are being developed to improve the performance of existing anti-cancer drugs by addressing limitations associated principally with their safety and use.  More information can be found on the Company's web site at www.adventrx.com.  

SOURCE ADVENTRX Pharmaceuticals, Inc.

Suggested Articles

Data from a 10,000-patient trial showed that people with osteoarthritis taking Novartis' Ilaris had 40% to 47% lower rates of joint replacements.

Immunic's lead asset beat placebo at reducing damage to myelin, which protects nerve fibers, in patients with relapsing multiple sclerosis.

The appointment sees Kobayashi switch from developing Dermira’s anti-IL-13 drug to advancing Aslan’s would-be rival.